The mechanisms by which T lymphocytes acquire the capacity to produce interleukin 4 (IL-4) and other lymphokines during intrathymic and extrathymic development are poorly understood. To gain insight into this process, we determined the capacity of human neonatal and adult T lineage cell populations to produce IL-4 after polyclonal activation. IL-2 and interferon-gamma (IFN-gamma) production were studied in parallel, since their production by neonatal T cells is known to be similar or diminished, respectively, compared to adult T cells. Production of IL-4 by neonatal CD4+ T cells and IFN-gamma by neonatal CD4+ and CD8+ T cells was markedly lower compared with analogous adult cell populations, whereas IL-2 production was similar. Transcription of IL-4, as determined by nuclear run-on assays, and IL-4 mRNA-containing cells, as determined by in situ hybridization, were undetectable in neonatal T cells, whereas both were detectable in adult T cells. IFN-gamma transcription and IFN-gamma mRNA-containing cells were reduced in neonatal T cells compared with adult T cells. Reduced lymphokine production by neonatal T cells correlated with their lack of a CD45R-(putative memory T cell) population; cells with this surface phenotype comprised 30-40% of the adult CD4+ T cells and were highly enriched for IL-4 and IFN-gamma, but not IL-2 production. IL-4, IFN-gamma, and IL-2 mRNA expression by neonatal CD4+CD8-thymocytes was similar to that found in […] T cells was markedly lower compared with analogous adult cell populations, whereas IL-2 production was similar. Transcription of IL4, as determined by nuclear run-on assays, and IL4 mRNA-containing cells, as determined by in situ hybridization, were undetectable in neonatal T cells, whereas both were detectable in adult T cells. IFN-'y transcription and IFN--y mRNAcontaining cells were reduced in neonatal T cells compared with adult T cells. Reduced lymphokine production by neonatal T cells correlated with their lack of a CD45R-(putative memory T cell) population; cells with this surface phenotype comprised 30-40% of the adult CD4' T cells and were highly enriched for IL4 and IFN--y, but not IL-2 production. IL-4, IFN-y, and IL-2 mRNA expression by neonatal CD4+CD8-thymocytes was similar to that found in circulating neonatal CD4+ T cells. Taken together, these findings suggest that the extrathymic generation of memory T cells during postnatal life may result in an increased capacity for IL4 and IFN-y gene expression. In addition, IFN-,y and IL-2 mRNA were significantly more abundant than IL4 mRNA in activated neonatal CD4+CD8-thymocytes and CD4+ T cells, as well as adult CD4' CD45R-T cells. Therefore, the capacity of T lineage cells to express the IL4 gene may be more restricted compared to other lymphokine genes beginning in intrathymic development. This restricted capacity appears to persist during postnatal extrathymic maturation of T cells. (J. Clin. Invest. 1991. 87:194-202.).
Introduction
Secretion of lymphokines such as the interleukins (IL) IL-2 and IL-4 and interferon-y (IFN-T) by activated T cells is an essen-tial component of antigen-specific immunity (1) (2) (3) . How T cells acquire, during their intrathymic and extrathymic maturation, the capacity to produce particular lymphokines remains largely unknown. Recently we have shown that virtually all IL-4 and most IFN-y produced by polyclonally activated adult CD4+ T cells is mediated by a CD45R-subset, whereas CD45R+ and CD45R-CD4+ T cells produce comparable amounts of IL-2 (4); the CD45R-subset, which is enriched in functional memory cells and is UCHL I', appears to be derived from CD45R+ (virgin) T cells which have been activated in vivo, presumably by suitably presented cognate antigen (5) (6) (7) (8) (9) . We reasoned that ifprevious in vivo activation is a major determinant of the capacity for T cells to produce IL-4 and IFN-y, then neonatal T cells, which presumably have had a minimal exposure to exogenous antigens, should exhibit a profile of lymphokine production similar to that of adult virgin T cells.
In agreement with this prediction, reduced IFN-'y production by neonatal T cells compared to adult T cells has been noted by us and other workers (10) (11) (12) (13) (14) . We now report that such a selective reduction in both IL-4 as well as IFN-,y gene expression by activated neonatal T cells does occur. This pattern of lymphokine production correlates with a uniformly CD45R+ surface phenotype on neonatal T cells, and is largely transcriptionally regulated. A similar selective reduction in and IFN-'y compared with IL-2 gene expression was observed in CD4+, CD8-thymocytes, suggesting that the results with neonatal T cells may reflect in part their antigenically naive status.
CD2-positive as assessed by flow cytometry after indirect immunofluorescent staining with MAb 9.6. CD4' and CD8' T cell subsets were purified by negative selection using MAb and complement: T cells were incubated with saturating concentrations of either OKT8 or 66.1 MAb, respectively, for 30 min at 4VC in RPMI-1640 medium (Mediatech, Washington, DC) containing 2% FCS (Hyclone Laboratories, Logan, UT). The anti-CD 16 MAb, FC-I was included in these incubations to deplete residual NK cells. After washing at 4VC, the cells were resuspended in RPMI medium with 20% (vol/vol) HLA-typing grade rabbit complement (Pel-Freez Biologicals, Brown Deer, WI) and incubated at 370C for I h with gentle agitation. Remaining viable cells were collected by Ficoll-Hypaque density gradient centrifugation and washed twice in RPMI medium with 2% fetal calf serum (FCS) before use. Adult CD4' T cells were further fractionated into CD45R' and CD45R-populations by incubation with MAb UCHLI or 3AC5, respectively, followed by negative selection with indirect panning (24) using plastic petri dishes (Baxter Scientific Products, McGaw Park, IL) previously coated with affinity-purified goat anti-mouse IgG (Tago Inc., Burlingame, CA). Human thymus samples were obtained from neonates undergoing cardiac surgery for congenital heart disease who were free of other significant congenital anomalies. After removal of fibrous capsular tissue and grossly visible blood vessels, samples were finely minced and pressed through sieves, and the viable thymocytes were collected by Ficoll-Hypaque centrifugation. CD4' CD8-singlepositive thymocytes were prepared by incubating unfractionated thymocytes with MAb OKT8 for 30 min at 4VC in RPMI medium with 2% FCS. The cells binding MAb were lysed using rabbit complement and the remaining viable cells subsequently isolated as described above for the purification ofthe CD4' and CD8' peripheral T cells. The purity of all T cell and thymocyte subsets was > 95% as determined by immunofluorescent flow cytometry after indirect staining with appropriate MAb.
T cell and thymocyte activation. Cells (5 x 106/ml) were incubated with either 0.5 ,1M ionomycin (Calbiochem-Behring Corp., San Diego, CA), 25 ,ug/ml concanavalin A (Con A; Pharmacia Fine Chemicals, Piscataway, NJ), or OKT3 (anti-CD3) MAb (18) (1:25 [vol/vol] of sterile azide-free ascites) in combination with 50 ng/ml phorbol myristate acetate (PMA; Sigma Chemical Co., St. Louis, MO); these concentrations were found to be optimal for lymphokine induction in preliminary experiments. RPMI 1640 medium containing 5% (vol/vol) human AB serum was used in all cases except for experiments assaying IL-4 and IFN-y protein in cell culture supernatants, for which AIM-V, a commercial serum-free medium (Gibco Laboratories, Grand Island, NY), was employed. Both media were supplemented with 2 mM L-glutamine, 50 U/ml penicillin G, and 50 Ag/ml streptomycin.
IL-4 and IFN-y protein assay. T cell culture supernatants were collected after 24 h of ionomycin and PMA treatment and concentrated using a Centricon-1O apparatus (Amicon Corp., Danvers, MA) In vitro transcription with isolated nuclei. Transcription assays were performed as previously described (26) , using nuclei isolated from T cells after 1.5 or 3 h of incubation with ionomycin and PMA. RNA blot analysis. Total cellular RNA was isolated by the guanidinium thiocyanate/CsCl method (27) , electrophoresed in 2.2 M formaldehyde, 1% agarose gels, blotted, hybridized, and washed as previously described (4, 14) . 32P-labeled RNA probes were synthesized from human IL-4 (28), IFN-y (29) , and IL-2 (30) cDNAs subcloned into transcription vectors, using a commercially available kit (Promega Biotech, Madison, WI). The human elongation factor I-a (EF)' cDNA probe (provided by R. Perlmutter, Univeisity of Washington) was 3p labeled by the random hexamer primer method (31) . The cDNAs were all full length except for IFN-y for which a 0.4-kb internal fragment was used (14) .
In situ hybridization. In situ hybridization was performed exactly according to the method of Pardoll et al. (32) , using 35S-labeled singlestranded anti-sense or sense RNA probes prepared from the IL-4, IFNy, and IL-2 cDNAs as previously described (4) . After counter staining with Diff-Quik reagent according to the manufacturer's instructions (Dade Diagnostics, Aguada, Puerto Rico) slides were permanently mounted and coded. For each slide, the number of grains over 300 individual cells was determined by counting 75 cells in each of four randomly selected fields free of obvious artifacts. Cells were considered positive for a mRNA species if their grain counts after hybridization with the antisense probe exceeded that of 99% of cells hybridized with the control sense probe.
Indirect immunofluorescent staining andflow cytometric analysis.
Unless otherwise indicated, PBS (pH 7.4) containing 1% BSA and 0.1% sodium azide was used to dilute all reagents and for cell washes. Cells were washed once and then incubated with saturating concentrations of diluted sterile MAb for 30 min at 4°C. After two washes, the cells were incubated with affinity purified fluorescein isothiocyanate (FITC)-labeled goat anti-mouse IgG or IgM F(ab')2 fragments (Tago Inc.) diluted 1:40 (vol/vol). The cells were subsequently washed three times and fixed in 2% paraformaldehyde/PBS for 5 min at room temperature, and then transfered to PBS. At least 3 x I03 cells per sample were analyzed using a flow cytometer (Epics C, Coulter Electronics, Inc., Hialeah, FL) equipped with a 2-W argon laser.
Results
Decreased production of IL-4 and IFN-,y by neonatal T cells.
After treatment with ionomycin and PMA, which induces maximal IL-4 and IFN-y production by adult T cells (4), concentrations exceeded 10 pM in cell culture supernatants from three different adult donors but were below the 3.5 pM limit of detectability in all neonatal samples (Table I) . Unlike IL-4, IFN-'y was detectable in all neonatal T cell culture supernatants, but in concentrations (25-30 pM) that were uniformly < 10% ofthose measured in adult T cell supernatants (Table I) , as reported previously (4, 13, 14) . Nevertheless, IFN-'y production by neonatal T cells was significantly greater than IL-4 pro-1. Abbreviations used in this paper: EF, elongation factor 1-a; LCA, leukocyte common antigen; PKC, protein kinase C. duction on a molar basis, as previously reported for adult T cells (4).
Decreased IL-4 and IFN-'y production reflects diminished gene transcription and mRNA accumulation. The production of IFN-y and IL-2 by T cells appears to be primarily regulated by the rate at which these lymphokine genes are transcribed (33) (34) (35) (36) (37) . To determine whether decreased IL-4 and IFN-'y protein production by neonatal T cells was also regulated in this manner, the transcription rates of the IL-4 and IFN-y genes were compared in cell nuclei purified from activated adult and neonatal T cells (Fig. 1) . The IL-2 gene, whose product is expressed in similar amounts by adult and neonatal T cells (I12- 14) , and the EF gene, whose transcript comprises -0.5% of mRNA in most types of mammalian cells (4) , were transcribed at similar rates by nuclei from adult and neonatal T cells and served as positive controls in these and subsequent experiments. IL-4 gene transcription by activated adult T cells was detectable as shown by the greater signal with the slot-blotted IL-4 cDNA plasmid than the negative control plasmid (Fig. I  B) . However, the IL-4 gene appeared to be transcribed in adult T cells at a markedly lower rate than the IFN-'y, IL-2, or EF genes, and, unlike these other genes, required high concentrations oflabelled nuclear RNA to detect its transcription ( Fig. 1 , A vs. B). In contrast, IL-4 gene transcription by neonatal T cells was not clearly detectable (as shown by a signal essentially equal to that of the negative control) even when high concentrations of labelled transcripts were used for hybridization ( Fig.  I B) , and the rate ofIFN--y gene transcription, although measurable, was much lower than in adult T cells (Fig. 1 A) . Thus, the Fig. 2 C, transcripts were observed at 24 h of incubation in neonatal and adult T cells, which had a lower apparent molecular weight than those which accumulated by 6 h of incubation (lanes 4, 7, and 11). However, these late-appearing transcripts were undetectable after hybridization with an IL-2 cDNA probe which lacked the last 100 bp of the 3' untranslated region but included the entire coding sequence (30) , whereas the earlier-appearing transcripts were still present (data not shown). Thus, these late-appearing transcripts presumably did not encode IL-2, but cross-hybridized with a portion of the 3 Grains /Cell Grains /Cell (Fig. 3, lanes I and 4) . Activated (Fig. 3, lanes 5 and 7) . The staining of this filter with methylene blue after hybridizations were completed indicated that equivalent amounts of ribosomal RNA were present in all lanes (data not shown). Similar results were obtained using CD4' CD8-thymocytes from older children (data not shown).
Discussion
We found that IL-4 production by unfractionated and CD4' neonatal T cells was markedly and consistently reduced compared to adult cells after polyclonal activation. We also found that IFN-,y production both by CD4' and CD8' neonatal T cells was diminished compared to adult cells, as previously reported for unfractionated T cells (4, 13, 14) . The decreased IL-4 and IFN--y production is selective in that production by neonatal and adult T cells of IL-2 (this report and references 4, and 12-14) and of tumor necrosis factor-a and -/B and the IL-2 receptor p55 chain ( 13, 46) In previous reports, reduced IFN-'y production by mitogen activated neonatal leukocytes or T cells has been variously attributed to suppression mediated by radiosensitive CD4+ or CD8+ T cell populations (47, 48) . However, our studies ofIFN--y mRNA expression in bulk cultures or at the individual cell level did not corroborate these findings in that purified CD4+ or CD8+ neonatal T cells did not accumulate substantially more IFN-,y or IL-4 mRNA than did unfractionated neonatal T cells. Although our results also do not exclude the possibility ofsuppression ofneonatal T cell IFN-'y and IL-4 production by a population found in both the CD4+ and CD8+ subsets, a more direct explanation is that reduced expression of these lymphokines is a feature intrinsic to naive T cells or, at least, T cells at this stage of development.
There is increasing evidence that memory T cells, defined as those which have previously been activated or "primed" by antigen, are capable of increased levels of Iymphokine production, compared to antigenically naive, virgin T cells. T cell fractionation studies making use of the mutually exclusive expression of CD45R and the 180-kD LCA isoform (recognized by MAb UCHL1 in humans), or markers coexpressed with the 180-kD isoform, such as 4B4 (CDw29), LFA-3, and in the mouse, PgP-1 (CD44), have demonstrated that postimmunization proliferative recall responses to soluble antigens, viruses, and alloantigens are mediated by CD45R-T cell populations (6- 9, 38, 49, 50 ). In humans, this memory T cell-enriched CD45R-subset accounts for virtually all IL-4 and most IFN-y produced by polyclonally activated adult CD4' T cells (4) , and IL-4 production by adult CD8' T cells also appears to be restricted to a CD45R-subpopulation (D. B. Lewis and C. B. Wilson, unpublished observations). Similarly in mice, CD4' or CD8' T cells with high surface levels of PgP-I are markedly enriched in IFN-,y production compared to PgP-1 dull or unfractionated T cells (51) . This enhanced lymphokine production is selective in that CD45R' and CD45R-, or PgP-l dull and PgP-1 bright T cell populations produce similar amounts of IL-2 (4,9,50). The observation originally made by Tedder et al. (5) and confirmed by others (43, 44) , that human neonatal T cells are uniformly CD45R' whereas circulating adult T cells are -60% CD45R', led them to propose that CD45R' T cells are converted to a CD45R-surface phenotype by a post-thymic maturational process involving, at least in part, T cell activation by cognate antigen (6) . The present study confirmed that both CD4+ and CD8+ neonatal T cells had a CD45R+ UCHLI-phenotype, consistent with their presumed antigenically naive status. This model is also supported by the fact that human neonatal or adult CD45R+ T cells polyclonally activated in vitro acquire a CD45R-UCHL1+ surface phenotype (7, 9, 40, 41) and by recent adoptive transfer studies in the rat directly demonstrating that CD45R+ T cells are the precursors of the antigen specific CD45R-memory population (52) .
Taken together, these findings strongly suggest that the similar amount of IL-2, but markedly diminished amounts of IL-4 and IFN-,y produced by neonatal T cells compared to adult T cells is due to the absence of an antigenically primed, or at least previously activated, memory T cell subpopulation.
Studies of postnatal T cell maturation also support a model in which increased lymphokine production is induced by antigenic priming. Mitogen-induced IFN-'y production by peripheral leukocytes increases with postnatal age, as does the number of circulating CD45R-T cells (43, 53) , although a direct connection between these events has not been established. Additional evidence comes from longitudinal studies of IFN--y production in humans after neonatal or adult infection with herpes simplex virus (HSV): peripheral blood mononuclear cells from 2-mo-old infants who were infected as neonates, produced as much IFN-'y in response to HSV antigen as cells from adults 2 mo after primary HSV infection, suggesting that once neonates developed T cells responsive to recall HSV antigens, the capacity of these cells to secrete IFN-'y was similar to that of T cells responding to the same antigen from infected adults (Burchett, S. K., K. Mohan, J. Westall, R. Ashley, L. Corey, and C. B. Wilson, manuscript submitted for publication). In cells from these infants, IFN-,y production after HSV antigen stimulation was equivalent to that observed after polyclonal activation with Con A, consistent with the notion that virtually all T cell-mediated IFN--y production was by memory cells. In contrast, adult T cells produced much larger amounts of IFN-y after Con A treatment than after HSV antigen stimulation, presumably because Con A activated significant num-bers of memory T cells directed against antigens other than HSV that would be expected to be present in adults but not in neonates. Whether antigen-specific IFN-,y production after neonatal or adult infection is predominantly mediated by CD45R-T cells, and antigen-specific IL-4 production parallels that for IFN-,y remains to be determined.
Although the above studies suggest that humans can develop functional memory T cells as early as 2 mo of age, they do not exclude the possibility that this ability is impaired at birth but rapidly matures during postnatal development. Several observations are consistent with this idea. First, in cells from infants infected with HSV as neonates, peak IFN-y production by memory T cells does not occur until -6 wk after infection, whereas adult cells achieve peak responses after only 2 weeks (Burchett, S. K., K. Mohan, J. Westall, R. Ashley, L. Corey, and C. B. Wilson, manuscript submitted for publication). Whether this delay reflects differences in events occurring proximal to T cell activation, such as in antigen-processing and presentation, or reflects a decrease in antigen-specific T cells or their ability to be clonally expanded, remains to be determined. In previous studies, the antigen-presenting ability of neonatal and adult mononuclear cells in vitro has been comparable (54) . Secondly, immunization of full-term infants with T-dependent antigens is often ineffective during the first 2 wk of life, but results in significant antibody responses when performed at 2 mo ofage (55) . Although decreased neonatal B cell function or interference by maternal antibodies has been proposed to account for these results, a maturational defect in cognate help by T cells is plausible. Finally, neonatal T cells obtained at birth express uniformly high levels of the CD38 antigen (recognized by MAb OKT10), which is also found on virtually all thymocytes but only very small numbers of circulating adult CD45R' T cells (56, 57 , and D. B. Lewis and C. B. Wilson, unpublished observations), suggesting that they are, in part, an immature, transitional population. The kinetics ofdisappearance for circulating CD38' T cells postnatally, and whether this population acquires a CD38-phenotype, or is replaced by a new population of CD38-T cells, remains to be determined. Because surface expression ofthe CD38 antigen is also increased after T cell activation (58) , this may limit its usefulness as a marker with which to follow the extrathymic maturation of neonatal T cells.
A direct comparison of the ability of neonatal and adult CD45R' T cells to develop into functional memory T cells would, therefore, be of interest. One approach is to compare lymphokine production by neonatal and adult CD45R' populations after in vitro priming. Priming of adult murine T cells using antigens, mitogens, or anti-CD3 MAb increases IL-4 and IFN--y, but not IL-2 production; this appears to mimic the in vivo process by which antigen activation selectively enhances lymphokine production (59) (60) (61) (62) . These studies are in progress.
Stimulated neonatal CD4+CD8-thymocytes contained undetectable amounts of IL-4 mRNA, and low levels of IFN--y mRNA compared to adult CD45R-CD4+ T cells, a pattern of lymphokine mRNA expression similar to that of circulating neonatal CD4+ or adult CD45R' CD4+ T cells. In addition, the greater capacity for IL-2 production by CD4+ and for IFN-'y production by CD8+ circulating neonatal T cells, is also observed for the CD4+ CD8-and CD4-CD8+ subsets of human thymocytes, respectively (D. B. Lewis, unpublished observations). Although these observations suggest that the capacity for lymphokine gene expression by circulating virgin T cell populations is largely determined during intrathymic differentiation, CD4' CD8-thymocytes also had modestly reduced levels of IL-2 mRNA compared to circulating CD45R' CD4' T cells. This may reflect the known heterogeneity within CD4' CD8-thymocytes (41, 45, 63) (4, 68) . Based on the results of in situ hybridization for lymphokine mRNA, this low level of production was due to the rarity of IL-4 producing cells. These findings suggest that during intrathymic as well as extrathymic T cell maturation, the capacity for T cells to produce IL-4 is relatively restricted, indicating that IL-4 may play a more specialized role in mediating T cell effector functions than does IFN--y or IL-2. It remains to be determined ifparticular T cells are permanently committed to produce IL-4 and/or IFN-y and the extent to which production of these lymphokines by primary T cells is mutually exclusive, a situation commonly observed among long-term murine CD4' T cell clones, but not among short-term murine or most human CD4' T cell clones (69) (70) (71) (72) (73) . Recently, mutually exclusive production ofIL-4 and IL-2 has been demonstrated for primary murine CD4' splenic T cells, fractionated on the basis ofreactivity with mAb against two uncharacterized T lineage determinants (74, 75) . It will be ofinterest to determine which ofthese CD4' splenocyte populations secrete IFN-'y, and whether analogous surface markers will also identify human primary T cells with specific patterns of lymphokine production.
